Historically, the usage of CGM for inpatient diabetes management has raised concerns about insulin stacking due to the all-time available glycemic data and subsequent hypoglycemia [32] or a state of clinical inertia due to a lack of operational algorithms on how to act on CGM data [35]. This evidence concerns the gene INS and diabetes mellitus.